4
Changes in Ownership
Axogen, Inc. Filed Acc 0001179110-20-005269
VP, Clinical&Translational Sc acquired 2,530 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2020-04-28 | Option exercise | +2,530 | $0.27 | $683 | 51,056 | D |
| Derivatives | |||||||
| DeVinney Erick Wayne VP, Clinical&Translational Sc | 2020-04-28 | Option exercise · Employee Stock Option (right to buy) | +2,530 | 0 | D | ||
Loading xslF345X03/edgar.xml…